ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $74,828,000 | -42.0% | 1,851,269 | -17.4% | 0.03% | -41.8% |
| Q2 2015 | $128,970,000 | -4.0% | 2,241,012 | +6.2% | 0.06% | -9.8% |
| Q1 2015 | $134,382,000 | +8.4% | 2,110,593 | +5.1% | 0.06% | +24.5% |
| Q4 2014 | $123,965,000 | +22.8% | 2,007,854 | -22.7% | 0.05% | +22.5% |
| Q3 2014 | $100,912,000 | +4.3% | 2,598,813 | -7.5% | 0.04% | -4.8% |
| Q2 2014 | $96,776,000 | +11.3% | 2,809,160 | +39.6% | 0.04% | +5.0% |
| Q1 2014 | $86,923,000 | +38.9% | 2,011,629 | +28.0% | 0.04% | +37.9% |
| Q4 2013 | $62,598,000 | +40.7% | 1,571,226 | +32.6% | 0.03% | +26.1% |
| Q3 2013 | $44,491,000 | +41.4% | 1,185,165 | +1.2% | 0.02% | +21.1% |
| Q2 2013 | $31,460,000 | – | 1,170,804 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |